177 related articles for article (PubMed ID: 35692857)
1. Assessing potential inhibitors of SARS-CoV-2 main protease from available drugs using free energy perturbation simulations.
Ngo ST; Nguyen HM; Thuy Huong LT; Quan PM; Truong VK; Tung NT; Vu VV
RSC Adv; 2020 Nov; 10(66):40284-40290. PubMed ID: 35692857
[TBL] [Abstract][Full Text] [Related]
2. Computational Determination of Potential Inhibitors of SARS-CoV-2 Main Protease.
Ngo ST; Quynh Anh Pham N; Thi Le L; Pham DH; Vu VV
J Chem Inf Model; 2020 Dec; 60(12):5771-5780. PubMed ID: 32530282
[TBL] [Abstract][Full Text] [Related]
3. Searching for potential inhibitors of SARS-COV-2 main protease using supervised learning and perturbation calculations.
Nguyen TH; Tam NM; Tuan MV; Zhan P; Vu VV; Quang DT; Ngo ST
Chem Phys; 2023 Jan; 564():111709. PubMed ID: 36188488
[TBL] [Abstract][Full Text] [Related]
4. Some Flavolignans as Potent Sars-Cov-2 Inhibitors
Cetin A
Curr Comput Aided Drug Des; 2022; 18(5):337-346. PubMed ID: 35975852
[TBL] [Abstract][Full Text] [Related]
5. Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery.
Ray AK; Sen Gupta PS; Panda SK; Biswal S; Bhattacharya U; Rana MK
Comput Biol Med; 2022 Mar; 142():105183. PubMed ID: 34986429
[TBL] [Abstract][Full Text] [Related]
6. Benchmark of Popular Free Energy Approaches Revealing the Inhibitors Binding to SARS-CoV-2 Mpro.
Ngo ST; Tam NM; Pham MQ; Nguyen TH
J Chem Inf Model; 2021 May; 61(5):2302-2312. PubMed ID: 33829781
[TBL] [Abstract][Full Text] [Related]
7. Identification of polyphenols from
Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
J Biomol Struct Dyn; 2021 Oct; 39(17):6747-6760. PubMed ID: 32762411
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors - an
Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
J Biomol Struct Dyn; 2021 Aug; 39(12):4362-4374. PubMed ID: 32568613
[TBL] [Abstract][Full Text] [Related]
9. Investigation of Iminosugars as Antiviral Agents against SARS-CoV-2 Main Protease: Inhibitor Design and Optimization, Molecular Docking, and Molecular Dynamics Studies to Explore Potential Inhibitory Effect of 1-Deoxynojirmycin Series.
Miglani V; Sharma P; Kumar Narula A
Curr Comput Aided Drug Des; 2023 Aug; ():. PubMed ID: 37612857
[TBL] [Abstract][Full Text] [Related]
10. Exploration of natural compounds with anti-SARS-CoV-2 activity via inhibition of SARS-CoV-2 Mpro.
Bharadwaj S; Dubey A; Yadava U; Mishra SK; Kang SG; Dwivedi VD
Brief Bioinform; 2021 Mar; 22(2):1361-1377. PubMed ID: 33406222
[TBL] [Abstract][Full Text] [Related]
11. Depicting the inhibitory potential of polyphenols from
Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
J Biomol Struct Dyn; 2022 Jun; 40(9):4110-4121. PubMed ID: 33292085
[TBL] [Abstract][Full Text] [Related]
12. Computer aided identification of potential SARS CoV-2 main protease inhibitors from diterpenoids and biflavonoids of
Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
J Biomol Struct Dyn; 2022 Apr; 40(6):2647-2662. PubMed ID: 33140695
[TBL] [Abstract][Full Text] [Related]
13. Analysis of bioactive compounds of
Almatroudi A
J Biomol Struct Dyn; 2023 Dec; ():1-12. PubMed ID: 38063160
[TBL] [Abstract][Full Text] [Related]
14. Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design.
Yu W; Wu X; Zhao Y; Chen C; Yang Z; Zhang X; Ren J; Wang Y; Wu C; Li C; Chen R; Wang X; Zheng W; Liao H; Yuan X
Molecules; 2021 Dec; 26(23):. PubMed ID: 34885967
[TBL] [Abstract][Full Text] [Related]
15. In silico discovery of novel inhibitors from Northern African natural products database against main protease (Mpro) of SARS-CoV-2.
Byadi S; Oblak D; Kassmi Y; Sadik K; Hachim ME; Podlipnik Č; Aboulmouhajir A
J Biomol Struct Dyn; 2023 Apr; 41(7):2900-2910. PubMed ID: 35168469
[TBL] [Abstract][Full Text] [Related]
16. Identification of alkaloids from
Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
J Mol Struct; 2021 Apr; 1229():129489. PubMed ID: 33100380
[TBL] [Abstract][Full Text] [Related]
17. Harnessing Brazilian biodiversity database: identification of flavonoids as potential inhibitors of SARS-CoV-2 main protease using computational approaches and all-atom molecular dynamics simulation.
da Rocha JAP; da Costa RA; da Costa ADSS; da Rocha ECM; Gomes AJB; Machado AK; Fagan SB; Brasil DDSB; Lima E Lima AH
Front Chem; 2024; 12():1336001. PubMed ID: 38456183
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 proteases Mpro and PLpro: Design of inhibitors with predicted high potency and low mammalian toxicity using artificial neural networks, ligand-protein docking, molecular dynamics simulations, and ADMET calculations.
Tumskiy RS; Tumskaia AV; Klochkova IN; Richardson RJ
Comput Biol Med; 2023 Feb; 153():106449. PubMed ID: 36586228
[TBL] [Abstract][Full Text] [Related]
19. Identification of potential plant-based inhibitor against viral proteases of SARS-CoV-2 through molecular docking, MM-PBSA binding energy calculations and molecular dynamics simulation.
Gogoi B; Chowdhury P; Goswami N; Gogoi N; Naiya T; Chetia P; Mahanta S; Chetia D; Tanti B; Borah P; Handique PJ
Mol Divers; 2021 Aug; 25(3):1963-1977. PubMed ID: 33856591
[TBL] [Abstract][Full Text] [Related]
20. In silico evaluation of Philippine Natural Products against SARS-CoV-2 Main Protease.
Cheng AJT; Macalino SJY; Billones JB; Balolong MP; Murao LAE; Carrillo MCO
J Mol Model; 2022 Oct; 28(11):345. PubMed ID: 36205801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]